The Drug Enforcement Administration proposes to establish the 2026 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine and phenylpropanolamine, a Federal Register notice says. Comments are due by Dec. 15.
The International Trade Commission published notices in the Nov. 28 Federal Register on the following antidumping and countervailing duty injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
EPA may be proposing an interpretation of the Toxic Substances Control Act that finds that the agency doesn't have the statutory authority to require reporting from those importing articles containing per- and polyfluoroalkyl substances (PFAS), according to attorneys with Bergeson and Campbell in a recent blog post on EPA's plans to amend PFAS regulations and allow certain exemptions to the scope of reporting PFAS (see 2511120028).
On Nov. 26, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices Nov. 28:
CBP issued the following releases on commercial trade and related matters:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Nov. 26, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP recently created Harmonized System Update 2540, containing two Automated Broker Interface records and one Harmonized Tariff Schedule record. It includes updates pursuant to the recent executive order cutting reciprocal tariffs on agricultural goods.
A Nov. 26 Cargo Systems Messaging Service message reminded the trade that they are able to protect user data in the ACE portal.
Manufacturing trade groups and companies mostly argued in comments to the U.S. Trade Representative that USMCA rules of origin for their sectors shouldn't change as part of the pact's review, and if they do, it should be only after extensive consultation with industry, and with adequate transition times.